Biomedical perspective on onabotulinumtoxinA: efficacy and clinical management in chronic migraine treatment. Research, Society and Development, [S. l.], v. 15, n. 5, p. e1215551006, 2026. DOI: 10.33448/rsd-v15i5.51006. Disponível em: https://rsdjournal.org/rsd/article/view/51006. Acesso em: 4 may. 2026.